Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Chordoma × Pemetrexed × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 200 Lung Neoplasms 72 Neoplasms 34 Mesothelioma 20 Mesothelioma, Malignant 18 Adenocarcinoma of Lung 18 Neoplasm Metastasis 17 Breast Neoplasms 16 Head and Neck Neoplasms 11 Colorectal Neoplasms 11 Ovarian Neoplasms 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Carcinoma 7 Uterine Cervical Neoplasms 6 Non-Squamous Non-Small Cell Lung Cancer 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Adenocarcinoma 6 Unspecified Adult Solid Tumor, Protocol Specific 5 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Recurrence 4 Pancreatic Neoplasms 4 Meningeal Carcinomatosis 4 Endometrial Neoplasms 4 Brain Neoplasms 4 Urinary Bladder Neoplasms 3 Solitary Fibrous Tumor, Pleural 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3

Interventions

Imatinib Mesylate 3 Nivolumab 2 relatlimab 1 palbociclib 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Proton Therapy 1 Photochemotherapy 1 Pemetrexed 1 Immunoglobulin G 1 Disulfides 1 Dihematoporphyrin Ether 1 Dasatinib 1 Cyclophosphamide 1 Blood Specimen Collection 1 Bacterial Load 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03955042 2023-03-07

Pemetrexed for the Treatment of Chordoma

Saint John's Cancer Institute

Phase 1 Completed

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡